In the latest issue of Frauenheilkunde Aktuell, the biannual magazine of the SGGG (Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe; en., Swiss Society of Gynecology and Obstetrics), the society’s president, Professor Michael Mueller, discusses the innovative WID-easy Test with Professor Martin Widschwendter, Director of the Institute for Prevention and Screening (EUTOPS).
Labor Team, the exclusive provider of the WID®-easy test in Switzerland, has launched the test with the support of Prof. Dr. Michael D. Mueller, President of the Swiss Society of Gynaecology and Obstetrics (SGGG), at its annual conference in Interlaken on June 28, 2024.
The WID®-can test is referred to in the scientific literature as the WID-qCIN test and is an epigenetic test for the detection and prediction of cervical cancer.
New data from the EUTOPS team, working with Prof. Joakim Dillner and his team from the Karolinska Institute, has been published in Nature Medicine.
The study investigated whether different sampling methods influence the validity of the WID®-easy test (“WID-qEC test” in the scientific literature)
Dr Chiara Herzog was honored with the “AGO – Young Scientist Award” for the scientific basis of the WID®-easy Test
